Mondor I - Search Results

1

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120.

Moulard M, Lortat-Jacob H, Mondor I, Roca G, Wyatt R, Sodroski J, Zhao L, Olson W, Kwong PD, Sattentau QJ. Moulard M, et al. Among authors: mondor i. J Virol. 2000 Feb;74(4):1948-60. doi: 10.1128/jvi.74.4.1948-1960.2000. J Virol. 2000. PMID: 10644368 Free PMC article.

2

Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations.

Gluschankof P, Mondor I, Gelderblom HR, Sattentau QJ. Gluschankof P, et al. Among authors: mondor i. Virology. 1997 Mar 31;230(1):125-33. doi: 10.1006/viro.1997.8453. Virology. 1997. PMID: 9126268 Free article.

3

HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4.

Ugolini S, Moulard M, Mondor I, Barois N, Demandolx D, Hoxie J, Brelot A, Alizon M, Davoust J, Sattentau QJ. Ugolini S, et al. Among authors: mondor i. J Immunol. 1997 Sep 15;159(6):3000-8. J Immunol. 1997. PMID: 9300725

4

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.

Parren PW, Mondor I, Naniche D, Ditzel HJ, Klasse PJ, Burton DR, Sattentau QJ. Parren PW, et al. Among authors: mondor i. J Virol. 1998 May;72(5):3512-9. doi: 10.1128/JVI.72.5.3512-3519.1998. J Virol. 1998. PMID: 9557629 Free PMC article.

5

Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.

Mondor I, Ugolini S, Sattentau QJ. Mondor I, et al. J Virol. 1998 May;72(5):3623-34. doi: 10.1128/JVI.72.5.3623-3634.1998. J Virol. 1998. PMID: 9557643 Free PMC article.

6

Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.

Mondor I, Moulard M, Ugolini S, Klasse PJ, Hoxie J, Amara A, Delaunay T, Wyatt R, Sodroski J, Sattentau QJ. Mondor I, et al. Virology. 1998 Sep 1;248(2):394-405. doi: 10.1006/viro.1998.9282. Virology. 1998. PMID: 9721247 Free article.

7

Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.

Esser MT, Mori T, Mondor I, Sattentau QJ, Dey B, Berger EA, Boyd MR, Lifson JD. Esser MT, et al. Among authors: mondor i. J Virol. 1999 May;73(5):4360-71. doi: 10.1128/JVI.73.5.4360-4371.1999. J Virol. 1999. PMID: 10196334 Free PMC article.

8

HIV-1 attachment: another look.

Ugolini S, Mondor I, Sattentau QJ. Ugolini S, et al. Among authors: mondor i. Trends Microbiol. 1999 Apr;7(4):144-9. doi: 10.1016/s0966-842x(99)01474-2. Trends Microbiol. 1999. PMID: 10217828 Review.

9

Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization.

Ugolini S, Mondor I, Parren PW, Burton DR, Tilley SA, Klasse PJ, Sattentau QJ. Ugolini S, et al. Among authors: mondor i. J Exp Med. 1997 Oct 20;186(8):1287-98. doi: 10.1084/jem.186.8.1287. J Exp Med. 1997. PMID: 9334368 Free PMC article.

10

Antibody neutralization of HIV-1 and the potential for vaccine design.

Sattentau QJ, Moulard M, Brivet B, Botto F, Guillemot JC, Mondor I, Poignard P, Ugolini S. Sattentau QJ, et al. Among authors: mondor i. Immunol Lett. 1999 Mar;66(1-3):143-9. doi: 10.1016/s0165-2478(98)00174-6. Immunol Lett. 1999. PMID: 10203047 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page